Mullins ES - Search Results

1

Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A.

Mullins ES, Stasyshyn O, Alvarez-Román MT, Osman D, Liesner R, Engl W, Sharkhawy M, Abbuehl BE. Mullins ES, et al. Haemophilia. 2017 Mar;23(2):238-246. doi: 10.1111/hae.13119. Epub 2016 Nov 27. Haemophilia. 2017. PMID: 27891721

2

Long-term safety and efficacy results from the phase 3b, open-label, multicentre Continuation study of rurioctocog alfa pegol for prophylaxis in previously treated patients with severe haemophilia A.

Chowdary P, Mullins ES, Konkle BA, McGuinn C, Park YS, Stasyshyn O, Zulfikar B, Engl W, Tangada S. Chowdary P, et al. Among authors: mullins es. Haemophilia. 2020 Jul;26(4):e168-e178. doi: 10.1111/hae.14052. Epub 2020 Jun 28. Haemophilia. 2020. PMID: 32597029 Clinical Trial.

3

Real-world experience with use of Antihemophilic Factor (Recombinant), PEGylated for prophylaxis in severe haemophilia A.

Dunn AL, Ahuja SP, Mullins ES. Dunn AL, et al. Among authors: mullins es. Haemophilia. 2018 May;24(3):e84-e92. doi: 10.1111/hae.13403. Epub 2018 Jan 23. Haemophilia. 2018. PMID: 29359417

4

Subcutaneous diphtheria and tetanus vaccines in children with haemophilia: A pilot study and review of the literature.

Schaefer BA, Gruppo RA, Mullins ES, Tarango C. Schaefer BA, et al. Among authors: mullins es. Haemophilia. 2017 Nov;23(6):904-909. doi: 10.1111/hae.13316. Epub 2017 Aug 6. Haemophilia. 2017. PMID: 28780770

5

The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development.

Reipert BM, Gangadharan B, Hofbauer CJ, Berg V, Schweiger H, Bowen J, Blatny J, Fijnvandraat K, Mullins ES, Klintman J, Male C, McGuinn C, Meeks SL, Radulescu VC, Ragni MV, Recht M, Shapiro AD, Staber JM, Yaish HM, Santagostino E, Brown DL. Reipert BM, et al. Among authors: mullins es. Blood Adv. 2020 Nov 24;4(22):5785-5796. doi: 10.1182/bloodadvances.2020002731. Blood Adv. 2020. PMID: 33232473 Free PMC article.

6

Successful management of concurrent acquired hemophilia A and a lupus anticoagulant in a pediatric hematopoietic stem cell transplant patient.

Jones L, Dandoy C, Jodele S, Myers KC, Luchtman-Jones L, Quinn CT, Mullins E, El-Bietar J. Jones L, et al. Bone Marrow Transplant. 2018 Apr;53(4):487-489. doi: 10.1038/s41409-017-0041-0. Epub 2018 Jan 12. Bone Marrow Transplant. 2018. PMID: 29330401 No abstract available.

7

The spectrum and severity of bleeding in adolescents with low von Willebrand factor-associated heavy menstrual bleeding.

Srivaths L, Minard CG, O'Brien SH, Wheeler AP, Mullins E, Sharma M, Sidonio R, Jain S, Zia A, Ragni MV, Kulkarni R, Dietrich JE, Kouides PA. Srivaths L, et al. Blood Adv. 2020 Jul 14;4(13):3209-3216. doi: 10.1182/bloodadvances.2020002081. Blood Adv. 2020. PMID: 32663297 Free PMC article.

8

Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations.

Sadler B, Minard CG, Haller G, Gurnett CA, O'Brien SH, Wheeler A, Jain S, Sharma M, Zia A, Kulkarni R, Mullins E, Ragni MV, Sidonio R, Dietrich JE, Kouides PA, Di Paola J, Srivaths L. Sadler B, et al. Blood Adv. 2022 Jan 25;6(2):420-428. doi: 10.1182/bloodadvances.2021005118. Blood Adv. 2022. PMID: 34807970 Free PMC article.

9

Urokinase plasminogen activator and receptor promote collagen-induced arthritis through expression in hematopoietic cells.

Thornton S, Raghu H, Cruz C, Frederick MD, Palumbo JS, Mullins ES, Almholt K, Usher PA, Flick MJ. Thornton S, et al. Among authors: mullins es. Blood Adv. 2017 Mar 21;1(9):545-556. doi: 10.1182/bloodadvances.2016004002. eCollection 2017 Mar 28. Blood Adv. 2017. PMID: 29296974 Free PMC article.

10

Elimination of the fibrinogen integrin α_Mβ₂-binding motif improves renal pathology in mice with sickle cell anemia.

Nasimuzzaman M, Arumugam PI, Mullins ES, James JM, VandenHeuvel K, Narciso MG, Shaw MA, McGraw S, Aronow BJ, Malik P. Nasimuzzaman M, et al. Among authors: mullins es. Blood Adv. 2019 May 14;3(9):1519-1532. doi: 10.1182/bloodadvances.2019032342. Blood Adv. 2019. PMID: 31076408 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters